Product news from the 09/12/06 News Brief

Share this article:
Barr Pharmaceuticals launched a generic version of its extended-cycle oral contraceptive Seasonale under the tradename Jolessa. The company launched this generic version of Seasonale following the final FDA approval of Watson Laboratories’ Abbreviated New Drug Application (ANDA) for a generic version of Seasonale. Watson received approval following the expiration of the Barr’s three-year new product exclusivity on Sept. 5, 2006. King Pharmaceuticals entered into an agreement with Ligand Pharmaceuticals to acquire rights to Avinza (morphine sulfate extended release). Avinza is an extended-release formulation of morphine and is indicated as a once-daily treatment for moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an extended period of time.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.